Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare Online Network.
Kane Biotech Showcases revyve™ Preclinical and Clinical Case Study Findings at North American Wound Care Conferences
GlobeNewswire, Inc.
·
July 30, 2025
Clinical case series showed clinically meaningful reductions in wound size and pain, and improved tissue regranulation in chronic wound patients using revyve® over 6–12 weeks Preclinical in vitro studies demonstrated >80% reduction in protease...
Tenaya Receives Positive Safety Reviews from Independent DSMBs to Advance Both TN-201 and TN-401 Gene Therapy Clinical Trials as Designed
GlobeNewswire, Inc.
·
July 30, 2025
Enrollment in Both Dose Cohorts of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Hypertrophic Cardiomyopathy (HCM) Complete; Follow-up Data from Cohort 1 and Initial Data from Cohort 2 Expected in Fourth Quarter of 2025 First Patient Dosed...
Arbor Biotechnologies Announces First Patient Dosed at Mayo Clinic in the redePHine Phase 1/2 Study of ABO-101, an Investigational Gene Editing Treatment for Primary Hyperoxaluria Type 1
GlobeNewswire, Inc.
·
July 30, 2025
- ABO-101 was well tolerated with no serious adverse events or dose-limiting toxicities reported in the 28-days following dosing - Phase 1/2 redePHine study (NCT06839235) dose escalation ongoing with enrollment at Mayo Clinic in the US and plans...
Registration Now Open for the 2026 MDA Clinical & Scientific Conference Where Global Leaders in Neuromuscular Disease Research & Care Unite to Drive the Next Breakthroughs March 8-11 in Orlando, FL
GlobeNewswire, Inc.
·
July 30, 2025
New York, July 30, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA), leader and innovator of the largest global gathering of the neuromuscular disease community, announced today that registration is open for the 2026 MDA Clinical...
Corbus Pharmaceuticals Announces Upcoming Presentation of Dose Expansion Phase 1/2 Clinical Data for its Nectin-4 Targeting ADC CRB-701 at the 2025 ESMO Annual Congress
GlobeNewswire, Inc.
·
July 30, 2025
NORWOOD, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, announced today that an abstract on updated clinical data from its Phase 1/2 clinical...
FDA Provides Trethera Clearance to Initiate TRE-515 Clinical Trial in Healthy Volunteers to Study Food Effect and Biomarkers
GlobeNewswire, Inc.
·
July 30, 2025
LOS ANGELES, July 30, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today that the U.S. Food and Drug...
Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025
GlobeNewswire, Inc.
·
July 30, 2025
BOSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, announced today that...
Virtual Bookkeeping Services Help U.S. Hospitality Businesses Maintain Financial Clarity
EIN Presswire
·
July 30, 2025
Virtual bookkeeping services help hospitality firms reduce overhead across locations. MIAMI, FL, UNITED STATES, July 30, 2025 /EINPresswire.com/ -- U.S. hospitality firms are tightening financial controls as economic pressure and rising...
NorvaNivel Launches Unite Table: A Smarter, Flexible Solution for Modern Learning & Hospitality Spaces
EIN Presswire
·
July 30, 2025
Unite Table offers flip-top innovation, integrated seating, and mobility—ideal for flexible learning, hospitality, and corporate spaces. DALLAS, TX, UNITED STATES, July 30, 2025 /EINPresswire.com/ -- NorvaNivel, a designer and manufacturer of...
ARC at Sheba Medical Center Launches Experiment on NASA / SpaceX Mission on Effect of Space on Disease-Causing Bacteria
EIN Presswire
·
July 30, 2025
Study on International Space Station will investigate how microgravity and space conditions influence bacterial virulence and antibiotic resistance RAMAT GAN, ISRAEL, July 30, 2025 /EINPresswire.com/ -- ARC, the global transformation engine and...
MOPE Clinic Highlights Clomiphene/Enclomiphene as Innovative Alternatives to Testosterone Replacement Therapy for Men
EIN Presswire
·
July 30, 2025
The Pros and Cons of Boosting Natural Testosterone Production with Selective Estrogen Receptor Modulators (SERMs) METAIRIE, LA, UNITED STATES, July 30, 2025 /EINPresswire.com/ -- Metairie, LA– As the conversation around men’s hormonal health...
UPDATE - Axonius Acquires Medical Device Security Specialist Cynerio for More Than $100 Million to Target Healthcare Market
GlobeNewswire, Inc.
·
July 30, 2025
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Axonius, the global leader in cyber asset intelligence, today announced that it has acquired Cynerio, a pioneer in medical device security for more than $100 million in a cash and stock transaction. The...
Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease
GlobeNewswire, Inc.
·
July 30, 2025
Vancouver, Canada, July 30, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived...
New York Academy of Medicine Welcomes Three Visionary Leaders to Its Board of Trustees
GlobeNewswire, Inc.
·
July 30, 2025
New York, NY, July 30, 2025 (GLOBE NEWSWIRE) -- New York Academy of Medicine (NYAM) has appointed three nationally recognized health leaders to its Board of Trustees, reinforcing its commitment to healthier, longer lives for everyone: Debra...
Outset Medical Names First Chief Nursing Officer
GlobeNewswire, Inc.
·
July 30, 2025
SAN JOSE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced Brittni McGill...
New Upsize™ Clinic for Men Opens in Bellevue, Bringing Revolutionary Upsize™ Procedure to Seattle Area
GlobeNewswire, Inc.
·
July 30, 2025
BELLEVUE, Wash., July 30, 2025 (GLOBE NEWSWIRE) -- The innovative Upsize™ Procedure has arrived in the Pacific Northwest with the recent opening of Upsize™ Clinic Seattle in Bellevue. Dr. Amit Grover and Dr. Adriana Rosales, who successfully...
ARC Medical Announces IPCOAT™ Medical Device Presentations at AAGL 2025
EIN Presswire
·
July 30, 2025
VANCOUVER, BRITISH COLUMBIA, CANADA, July 30, 2025 /EINPresswire.com/ -- ARC Medical Inc., a clinical stage medical device company focused on advancing surgical adhesion prevention, today announced that three scientific abstracts highlighting...
NetraMark Announces Partnership with Pentara to Detect Anomalous Site and Participant Behavior and Safeguard Clinical Trial Integrity
GlobeNewswire, Inc.
·
July 30, 2025
TORONTO, July 30, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company transforming clinical trials and Pentara Corporation...
Questex Aligns Hospitality Portfolio Under Unified Leadership, Appoints Brandy Rand as VP Market Leader and Elliot Howell as Sales Leader
GlobeNewswire, Inc.
·
July 30, 2025
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Questex, the leading information and event services company focused on the experience economy, today announces a new unified leadership structure for its Hospitality division bringing together...
Avacta to Present New FAP Dox (AVA6000) Data at the European Society for Medical Oncology (ESMO) Congress
GlobeNewswire, Inc.
·
July 30, 2025
LONDON and PHILADELPHIA, July 30, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, ‘the Company’), a life sciences company developing innovative, targeted oncology drugs, today announces that the Company will present an updated data...